Gamma-Ray Constant & Point-Source Dose

Q: What is the specific gamma-ray constant?

The specific gamma-ray constant is a radionuclide-specific number that gives the dose rate at a fixed reference distance, usually one meter, per unit activity of an unshielded point source. In modern SI usage it is the air-kerma rate constant, expressed in units such as microgray times meter squared per megabecquerel per hour, and it lets you convert an activity directly into an external dose rate at distance.

Q: How do you calculate dose rate from a point source?

Multiply the air-kerma rate constant by the activity and divide by the square of the distance in meters. For a source of 1000 megabecquerel of iodine-131 at one meter, with a constant near 0.052 microgray times meter squared per megabecquerel per hour, the unshielded dose rate is about 52 microgray per hour; at two meters it falls by a factor of four to about 13 microgray per hour.

Q: Does the specific gamma-ray constant include beta and alpha radiation?

No. The constant accounts only for the penetrating photon (gamma, characteristic X-ray, and internal bremsstrahlung) emissions above the chosen energy cutoff. Beta particles and alpha particles are handled separately, because they are short-range and, for most emitters, are stopped by the source container, so they contribute to contamination and skin-dose concerns rather than to penetrating external dose at a distance; energetic beta emitters such as Y-90 are the exception, because their beta particles can travel meters in air and their bremsstrahlung is penetrating, so they need a separate skin-dose and photon-shielding assessment.

Q: How is shielding added to a point-source dose calculation?

Multiply the unshielded dose rate by a transmission factor that accounts for attenuation in the barrier. For narrow-beam geometry the transmission is an exponential in the linear attenuation coefficient and thickness; for realistic broad-beam geometry a buildup factor is added, or tabulated half-value and tenth-value layers for the specific radionuclide are used, because scattered photons increase the dose behind the barrier.

Q: What are the main limitations of the point-source model?

The model assumes a small, unshielded point source, negligible attenuation in air, no source self-absorption, and observation distances that are large compared with the source dimensions. Real sources have finite size, self-attenuation, container shielding, and decay during the exposure, so the constant gives only a first estimate that should be refined for distributed sources, extended exposures, and broad-beam shielding.

The specific gamma-ray constant is the single number that converts the activity of a photon-emitting radionuclide into a dose rate at a fixed distance, and it is the workhorse of everyday external-dose estimation in radiation safety. Combined with the inverse-square law and broad-beam shielding data, it lets a radiation safety officer estimate the dose rate from a vial, a syringe, a waste container, a sealed source, or a treated patient in a single line of arithmetic.¹

In modern practice the quantity is expressed as the air-kerma rate constant, the SI successor to the older exposure-based constant. Understanding what it includes — and, just as importantly, what it excludes — is fundamental to defensible dose calculations, time-distance-shielding decisions, and license documentation.¹³

Introduction

Almost every external-dose question in a nuclear medicine or radioactive-materials program reduces to the same three ingredients: how much activity, how far away, and how much shielding. The specific gamma-ray constant supplies the first link in that chain by turning activity into a dose rate at a reference distance.

Because it is radionuclide-specific and derived from fundamental decay and attenuation data, the constant is both convenient and rigorous — provided its assumptions are respected. A number that is perfect for a compact iodine-131 source in a drawer can badly mislead if it is applied to a large distributed source without correction.¹

A note on terminology. In this guide, "dose rate" is used in the everyday radiation-safety sense of the unshielded air-kerma rate (historically, the exposure rate) at a point. It is not absorbed dose in tissue, personal dose equivalent, or effective dose; those require further conversion coefficients.³

This guide defines the specific gamma-ray constant and its modern air-kerma-rate-constant form, shows how it combines with the inverse-square law and broad-beam shielding, provides representative values for common medical radionuclides, works through a complete example, explains the clinical and operational stakes, offers practical tips, sets the regulatory context, and lists the verification steps that keep an external-dose calculation defensible.

Topic Explanation

What is the specific gamma-ray constant?

The specific gamma-ray constant, $Γ$ , is the dose rate at a fixed reference distance per unit activity of an unshielded point source of a given radionuclide. Historically it was defined in terms of exposure, with units of roentgen·cm²·mCi⁻¹·h⁻¹, and it counted only the penetrating photon emissions of the nuclide.¹

The modern SI quantity is the air-kerma rate constant, $Γ_{δ}$ , defined for an ideal point source in vacuo as the air-kerma rate at 1 m per unit activity for photons of energy greater than a cutoff $δ$ :

Γ_{δ} = \frac{d ^{2} K ˙ _{air}}{A}

where $\dot{K}_{air}$ is the air-kerma rate at distance $d$ from an ideal point source of activity $A$ (in vacuo, so air attenuation and scatter are neglected). Convenient units are µGy·m²·MBq⁻¹·h⁻¹, i.e., the air kerma in µGy per hour at 1 m from a 1 MBq source. The energy cutoff $δ$ (often a few keV to tens of keV) excludes very-low-energy photons that would be absorbed in the source or its container and would not contribute to penetrating external dose.¹³

Why it excludes beta and alpha emissions

The constant is a photon quantity. Beta particles and alpha particles are short-range: the particles of lower-energy beta emitters are largely stopped by the source vial or a few millimeters of plastic, and alpha particles travel only centimeters in air and are stopped by a sheet of paper or the dead layer of skin. These emissions matter enormously for contamination control and skin dose, but they contribute little to the penetrating external dose at a meter, so they are handled by separate methods, not by $Γ$ ; energetic beta emitters such as Y-90 are the exception: their beta particles can travel meters in air and are a direct skin-dose hazard, and they produce penetrating bremsstrahlung when the beta particles are stopped in the source, container, or shielding, which needs its own photon-shielding assessment.¹⁴

From constant to dose rate: the inverse-square law

Once $Γ$ is known, the unshielded dose rate at distances large compared with the source dimensions follows from the inverse-square law, because a point source radiates into an expanding sphere:

\dot{K} (d) = \frac{Γ A}{d ^{2}}

Doubling the distance quarters the dose rate; halving it quadruples the dose rate. Distance is therefore the most powerful and cheapest dose-reduction tool available, which is why it is one of the three cardinal principles of external radiation protection alongside time and shielding.

Key Technical Principles

Representative air-kerma rate constants

The table below lists representative air-kerma rate constants for radionuclides common in medical imaging and therapy. These are illustrative starting values that vary across published datasets depending on the decay data, energy cutoff, and air attenuation assumptions; a defensible calculation should use a verified value for the specific dataset and radionuclide.¹

Radionuclide	Principal photon energies	Representative $Γ_{δ}$ (µGy·m²·MBq⁻¹·h⁻¹)	Common use
Tc-99m	140 keV	~0.014–0.022	General nuclear medicine imaging
I-123	159 keV	~0.04	Thyroid and DaTscan imaging
F-18	511 keV (annihilation)	~0.13–0.14	PET imaging
I-131	364 keV (plus others)	~0.05–0.07	Thyroid therapy and imaging
Cs-137	662 keV	~0.077–0.081	Calibration and check sources
Co-60	1.17 and 1.33 MeV	~0.31–0.35	Calibration and irradiators

The pattern is instructive: the constant broadly increases with photon energy and photon yield, so high-energy emitters such as Co-60 produce far higher dose rates per unit activity than a low-energy emitter such as Tc-99m. Values should be confirmed against a primary compilation before use in a formal calculation.¹

Adding shielding: narrow beam, broad beam, and buildup

Introducing a barrier of thickness $x$ multiplies the unshielded dose rate by a transmission factor. In idealized narrow-beam geometry, transmission is a simple exponential:

\dot{K} (d) = \frac{Γ A}{d ^{2}} e^{- μx}

where $μ$ is the linear attenuation coefficient of the barrier at the photon energy. Real shielding, however, sees broad-beam geometry, in which photons scattered within the barrier reach the point of interest and increase the dose. This is captured by a buildup factor $B \geq 1$ :

\dot{K} (d) = \frac{Γ A}{d ^{2}} B (μx) e^{- μx}

For practical work, physicists more often use tabulated half-value layers (HVL) and tenth-value layers (TVL) that already incorporate broad-beam conditions for a specific radionuclide and shielding material. If the value layer is treated as constant, the barrier thickness needed to achieve a target transmission $T$ is approximately:

x = TVL \cdot lo g_{10} (\frac{1}{T})

This single-value-layer form is most reliable near the tabulated reduction: because buildup and beam hardening change with thickness, successive value layers are not exactly equal, so for large reductions use the tabulated transmission data or fitted broad-beam parameters for the radionuclide rather than repeating one TVL.¹⁶ Using HVL and TVL data appropriate to the radionuclide and to broad-beam geometry is essential, because a narrow-beam calculation systematically underestimates the shielding required.⁵⁶ Structural shielding for diagnostic x-ray rooms follows a different methodology, based on workload, use, and occupancy factors, and is described in NCRP Report No. 147; it addresses x-ray imaging rooms rather than radionuclide sources.²

Worked example: an I-131 source

Consider an unshielded point source of 1000 MBq (1 GBq) of iodine-131, using a representative air-kerma rate constant of $Γ_{δ} = 0.052 μ Gy\cdotm^{2} \cdotMBq^{- 1} \cdoth^{- 1}$ .¹

Step 1 — dose rate at 1 m:

\dot{K} (1 m) = \frac{0.052 \times 1000}{1 ^{2}} = 52 μ Gy/h

Step 2 — dose rate at 2 m (inverse square):

\dot{K} (2 m) = \frac{0.052 \times 1000}{2 ^{2}} = 13 μ Gy/h

Moving from 1 m to 2 m cuts the dose rate to one quarter — a dramatic reduction from a single step backward.

Step 3 — add lead shielding. Suppose we want to reduce the 1 m dose rate by a factor of ten, to about 5.2 µGy/h. Using a representative broad-beam tenth-value layer for I-131 in lead of approximately 1.1 cm (about 11 mm, a rounded-up value near published broad-beam data for I-131 in lead;¹ the narrow-beam value calculated from NIST attenuation data is about 0.7 cm,⁵ and buildup raises the thickness needed):

x = 1.1 \cdot lo g_{10} (\frac{1}{0.1}) = 1.1 \cdot 1 = 1.1 cm of lead

So roughly 1.1 cm of lead (one TVL) reduces the I-131 dose rate tenfold. Combining distance and shielding — for example standing at 2 m and placing the source behind 1.1 cm of lead — reduces the original 52 µGy/h to about 1.3 µGy/h. This is time-distance-shielding made quantitative, and it is exactly how a shielded transport or storage configuration is justified. These same constants underlie the selection of point-of-use shields.

Accounting for decay and time

For an extended exposure, the activity — and therefore the dose rate — falls as the source decays. The time-integrated dose over an interval $Δ t$ uses the average activity, which for initial activity $A_{0}$ and decay constant $λ$ is:

\overset{ˉ}{A} = A_{0} \cdot \frac{1 - e ^{- λ Δ t}}{λ Δ t}

For short exposures relative to the half-life, $\overset{ˉ}{A} \approx A_{0}$ and decay can be neglected; for exposures comparable to or longer than the half-life, using the initial activity overestimates the dose, which is conservative but may over-shield or over-restrict. Cumulative-dose estimates for treated patients use exactly this kind of time integration.⁷

Clinical Impact

The specific gamma-ray constant is where radiation safety becomes a number a technologist, nurse, or RSO can act on. It converts an abstract activity on a label into a concrete dose rate that drives real decisions:

Staff protection. Estimating the dose rate at the working distance from a hot vial, a generator, or an injected patient sets the basis for time limits, distance rules, and portable shielding.
Patient release. After radioiodine or other therapy, the dose rate at 1 m from the patient is one input to the release decision. Under 10 CFR 35.75 the criterion is that the total effective dose equivalent to any other individual is not likely to exceed 5 mSv,⁹ and NRC guidance allows release based on administered-activity thresholds, measured dose-rate thresholds, or a patient-specific calculation that accounts for occupancy and biokinetics;¹¹ a patient is not a point source.
Facility and storage design. Dose rates from waste in decay-in-storage, from sealed calibration sources, and from hot-lab inventory determine barrier and layout requirements.
Emergency response. In a lost-source event involving a compact source, a rapid point-source estimate gives responders a first indication of dose rate versus distance and time. Spills and other contamination events also need surveys and assessment of skin dose and intake, because the constant covers only penetrating photons from a point source.⁸

Because the calculation is transparent and radionuclide-specific, it also makes the reasoning auditable: an inspector or reviewer can follow the activity, distance, constant, and shielding assumptions and confirm the conclusion.¹⁸

Practical Optimization Tips

Use verified radionuclide data

Confirm the constant against a primary compilation. Values differ across datasets; use a documented source such as an established exposure-rate/air-kerma-rate-constant compilation and record the value and reference.¹
Match the energy cutoff and geometry to the problem. A constant tabulated for a bare point source may not suit a source inside a thick container; account for container attenuation separately when it matters.
Prefer broad-beam HVL/TVL for barriers. Narrow-beam attenuation underestimates real shielding; use broad-beam data or an explicit buildup factor.⁵⁶

Respect the model's assumptions

Point-source approximation. The inverse-square law is exact only for a point source; at distances comparable to the source dimensions, treat the source as extended.
Air attenuation. For most in-room distances, air attenuation is negligible and conservatively ignored; over long distances it is not.
Self-absorption and decay. Large or self-shielding sources deliver less than the bare-source estimate; long exposures should use time-integrated (decay-corrected) activity.⁷

Combine the three cardinal principles

The most effective dose reduction usually combines all three levers rather than relying on shielding alone:

Time — minimize the interval near the source.
Distance — exploit the inverse square; a step back is free shielding.
Shielding — add material where time and distance are insufficient.

Avoid common errors

Confusing exposure and air-kerma constants — mixing R·cm²·mCi⁻¹·h⁻¹ and µGy·m²·MBq⁻¹·h⁻¹ without converting produces large errors.
Applying a single constant to a beta or alpha emitter's total hazard — the constant covers only penetrating photons.⁴
Using narrow-beam attenuation for a real barrier — it under-shields.⁵
Ignoring buildup, self-absorption, or decay — each shifts the estimate, sometimes substantially.
Failing to document the value and source — an undocumented constant is not defensible at inspection.

Regulatory Considerations

External-dose and shielding calculations built on the specific gamma-ray constant underpin compliance with occupational and public dose limits. The constant itself is not regulated, but the dose limits it is used to demonstrate compliance with are enforceable.

10 CFR Part 20 sets the occupational dose limits and the dose limits to members of the public that a point-source or shielding calculation is designed to satisfy, and it establishes ALARA as the governing principle.⁸ Internationally, IAEA GSR Part 3 sets the corresponding basic safety requirements.¹⁰
10 CFR Part 35 governs medical use of byproduct material, including surveys, patient release, and the radiation safety officer's responsibilities that rely on external-dose estimates.⁹
NCRP Report No. 155 provides guidance on managing radionuclide-therapy patients, including release considerations, instructions to patients and family members, and records.⁷
Radionuclide decay data — the ICRP Publication 107 dataset and its derivatives underlie modern constants; ICRU Report 85 defines the air-kerma quantities used.³⁴

Agreement States administer parallel programs. DRPS serves Florida (Chapter 64E-5), Maryland, Virginia, Washington DC, California, Nevada, Pennsylvania, New York, New Jersey, and Delaware; the specific dose limits, survey, and documentation requirements should be confirmed with the authority having jurisdiction.

Frequently Asked Questions (FAQs)

What is the specific gamma-ray constant?

It is a radionuclide-specific number giving the dose rate at a fixed reference distance (usually 1 m) per unit activity of an unshielded point source. In SI usage it is the air-kerma rate constant, in units such as µGy·m²·MBq⁻¹·h⁻¹, and it converts activity directly into an external dose rate at distance.¹

What is the difference between the specific gamma-ray constant and the air-kerma rate constant?

They express the same idea using different quantities and units. The older specific gamma-ray constant used exposure (R·cm²·mCi⁻¹·h⁻¹); the air-kerma rate constant is the SI replacement defined in terms of air kerma for photons above an energy cutoff, and it is used in current dosimetry and shielding work.¹³

How do you calculate dose rate from a point source?

Multiply the constant by the activity and divide by the distance squared. For 1000 MBq of I-131 at 1 m, with a constant near 0.052 µGy·m²·MBq⁻¹·h⁻¹, the unshielded dose rate is about 52 µGy/h; at 2 m it falls to about 13 µGy/h.¹

Does the specific gamma-ray constant include beta and alpha radiation?

No. It accounts only for penetrating photon emissions above the energy cutoff. Beta and alpha emissions are short-range and are treated separately as contamination and skin-dose concerns.¹⁴

How is shielding added to a point-source dose calculation?

Multiply by a transmission factor. Narrow-beam geometry uses a simple exponential in $μx$ ; realistic broad-beam geometry adds a buildup factor or uses radionuclide-specific broad-beam HVL/TVL data, because scattered photons increase the dose behind the barrier.⁵⁶

What are the main limitations of the point-source model?

It assumes a small, unshielded point source, negligible air attenuation, no self-absorption, and observation distances that are large compared with the source dimensions. Real sources have finite size, self-attenuation, container shielding, and decay during exposure, so the constant gives only a first estimate that should be refined for distributed sources and long exposures.¹⁷

Who should perform external dose and shielding calculations?

External dose-rate and shielding calculations that support a radiation safety program, a license application, or a facility design are typically prepared or reviewed by a qualified or board-certified medical physicist or health physicist, using verified radionuclide data and documented assumptions.

Key Takeaways

The specific gamma-ray constant converts activity into dose rate at a reference distance; its SI form is the air-kerma rate constant, $Γ_{δ}$ , in µGy·m²·MBq⁻¹·h⁻¹.¹³
Point-source dose rate follows the inverse-square law, $\dot{K} (d) = Γ A / d^{2}$ , making distance a powerful dose-reduction tool.¹
The constant covers only penetrating photons above an energy cutoff; beta and alpha emissions are handled separately.¹⁴
The constant rises with photon energy and yield, so Co-60 delivers far more dose per unit activity than Tc-99m.¹
Realistic shielding uses broad-beam HVL/TVL data or a buildup factor; narrow-beam attenuation under-shields.⁵⁶
The method underpins staff protection, patient release, storage and facility design, and first-pass emergency-response estimates, and it must be documented with verified data to be defensible.⁷⁸

Conclusion

The specific gamma-ray constant is deceptively simple: one radionuclide-specific number, an inverse-square correction, and a shielding factor. Yet that compact toolkit answers the majority of external-dose questions a radiation safety program faces — from how far a technologist should stand, to whether a therapy patient can be released, to how much lead a storage safe needs. Its power depends on discipline: use verified data, respect the point-source and broad-beam assumptions, account for decay over long exposures, and document every value. Applied that way, the constant turns radiation protection from guesswork into a transparent, auditable calculation.¹⁸

How DRPS Can Help

Diagnostic Radiation Physics Services (DRPS) supports imaging and nuclear medicine facilities across Florida, Maryland, Virginia, Washington DC, California, Nevada, Pennsylvania, New York, New Jersey, and Delaware with external-dose and radiation shielding design calculations, patient-release and storage assessments, radiation safety officer consulting, radiation safety training, and medical physicist consulting performed by board-certified medical physicists.

A strong external-dose program is not a single number pulled from a chart. It is a documented, verified method — activity, distance, constant, and shielding — that protects staff and the public while standing up to inspection.

Related Resources

References

Smith DS, Stabin MG. Exposure rate constants and lead shielding values for over 1,100 radionuclides. Health Physics. 2012;102(3):271-291. doi:10.1097/HP.0b013e318235153a. PubMed
National Council on Radiation Protection and Measurements. Structural Shielding Design for Medical X-Ray Imaging Facilities. NCRP Report No. 147. Bethesda, MD: NCRP; 2004. ncrponline.org
International Commission on Radiation Units and Measurements. Fundamental Quantities and Units for Ionizing Radiation. ICRU Report 85. Journal of the ICRU. 2011;11(1). icru.org
International Commission on Radiological Protection. Nuclear Decay Data for Dosimetric Calculations. ICRP Publication 107. Annals of the ICRP. 2008;38(3). icrp.org
National Institute of Standards and Technology. X-Ray Mass Attenuation Coefficients and Mass Energy-Absorption Coefficients (NIST Standard Reference Database 126). Hubbell JH, Seltzer SM. nist.gov
Madsen MT, Anderson JA, Halama JR, et al. AAPM Task Group 108: PET and PET/CT shielding requirements. Medical Physics. 2006;33(1):4-15. doi:10.1118/1.2135911. aapm.onlinelibrary.wiley.com
National Council on Radiation Protection and Measurements. Management of Radionuclide Therapy Patients. NCRP Report No. 155. Bethesda, MD: NCRP; 2006. ncrponline.org
U.S. Nuclear Regulatory Commission. 10 CFR Part 20, Standards for Protection Against Radiation. ecfr.gov
U.S. Nuclear Regulatory Commission. 10 CFR Part 35, Medical Use of Byproduct Material. ecfr.gov
International Atomic Energy Agency. Radiation Protection and Safety of Radiation Sources: International Basic Safety Standards. IAEA Safety Standards Series No. GSR Part 3. Vienna: IAEA; 2014. iaea.org
U.S. Nuclear Regulatory Commission. Release of Patients Administered Radioactive Material. Regulatory Guide 8.39, Revision 1. April 2020. nrc.gov

Introduction

Topic Explanation

What is the specific gamma-ray constant?

Why it excludes beta and alpha emissions

From constant to dose rate: the inverse-square law

Key Technical Principles

Representative air-kerma rate constants

Adding shielding: narrow beam, broad beam, and buildup

Worked example: an I-131 source

Accounting for decay and time

Clinical Impact

Practical Optimization Tips

Use verified radionuclide data

Respect the model's assumptions

Combine the three cardinal principles

Avoid common errors

Regulatory Considerations

Frequently Asked Questions (FAQs)

What is the specific gamma-ray constant?

What is the difference between the specific gamma-ray constant and the air-kerma rate constant?

How do you calculate dose rate from a point source?

Does the specific gamma-ray constant include beta and alpha radiation?

How is shielding added to a point-source dose calculation?

What are the main limitations of the point-source model?

Who should perform external dose and shielding calculations?

Key Takeaways

Conclusion

How DRPS Can Help

Related Resources

References

Related Articles